Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Quinalizarin inhibits adipogenesis through down-regulation of transcription factors and microRNA modulation.

Schwind L, Nalbach L, Zimmer AD, Kostelnik KB, Menegatti J, Grässer F, Götz C, Montenarh M.

Biochim Biophys Acta Gen Subj. 2017 Dec;1861(12):3272-3281. doi: 10.1016/j.bbagen.2017.09.018. Epub 2017 Sep 28.

PMID:
28964816
2.

A cleavable cytolysin-neuropeptide Y bioconjugate enables specific drug delivery and demonstrates intracellular mode of action.

Ahrens VM, Kostelnik KB, Rennert R, Böhme D, Kalkhof S, Kosel D, Weber L, von Bergen M, Beck-Sickinger AG.

J Control Release. 2015 Jul 10;209:170-8. doi: 10.1016/j.jconrel.2015.04.037. Epub 2015 Apr 30.

PMID:
25935706
3.

High metabolic in vivo stability and bioavailability of a palmitoylated ghrelin receptor ligand assessed by mass spectrometry.

Kostelnik KB, Els-Heindl S, Klöting N, Baumann S, von Bergen M, Beck-Sickinger AG.

Bioorg Med Chem. 2015 Jul 15;23(14):3925-32. doi: 10.1016/j.bmc.2014.12.008. Epub 2014 Dec 10.

PMID:
25541202
4.

Quantitative impedimetric NPY-receptor activation monitoring and signal pathway profiling in living cells.

te Kamp V, Lindner R, Jahnke HG, Krinke D, Kostelnik KB, Beck-Sickinger AG, Robitzki AA.

Biosens Bioelectron. 2015 May 15;67:386-93. doi: 10.1016/j.bios.2014.08.066. Epub 2014 Sep 2.

PMID:
25239555
5.

Active contractions in single suspended epithelial cells.

Gyger M, Stange R, Kießling TR, Fritsch A, Kostelnik KB, Beck-Sickinger AG, Zink M, Käs JA.

Eur Biophys J. 2014 Jan;43(1):11-23. doi: 10.1007/s00249-013-0935-8. Epub 2013 Nov 7.

PMID:
24196420

Supplemental Content

Loading ...
Support Center